PubMed=11431363
Chen J.J.W., Peck K., Hong T.-M., Yang S.-C., Sher Y.-P., Shih J.-Y., Wu R., Cheng J.-L., Roffler S.R., Wu C.-W., Yang P.-C.
Global analysis of gene expression in invasion by a lung cancer model.
Cancer Res. 61:5223-5230(2001)

PubMed=19597463; DOI=10.1038/onc.2009.187; PMCID=PMC2763377
Sher Y.-P., Tzeng T.-F., Kan S.-F., Hsu J.L., Xie X., Han Z., Lin W.-C., Li L.-Y., Hung M.-C.
Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival.
Oncogene 28:3286-3295(2009)

PubMed=24705471; DOI=10.1371/journal.pone.0094065; PMCID=PMC3976390
Sher Y.-P., Wang L.-J., Chuang L.-L., Tsai M.-H., Kuo T.-T., Huang C.-C., Chuang E.Y., Lai L.-C.
ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells.
PLoS ONE 9:E94065-E94065(2014)

PubMed=25060522; DOI=10.1158/0008-5472.CAN-13-2995
Lin C.-Y., Chen H.-J., Huang C.-C., Lai L.-C., Lu T.-P., Tseng G.-C., Kuo T.-T., Kuok Q.-Y., Hsu J.L., Sung S.-Y., Hung M.-C., Sher Y.-P.
ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway.
Cancer Res. 74:5229-5243(2014)